These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22136837)

  • 61. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
    Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
    Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
    Samulski TD; Livolsi VA; Montone K; Baloch Z
    Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Postoperative calcitonin study in medullary thyroid carcinoma.
    Ismailov SI; Piulatova NR
    Endocr Relat Cancer; 2004 Jun; 11(2):357-63. PubMed ID: 15163310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma.
    Parra-Robert M; Orois A; Augé JM; Halperin I; Filella X; Molina R
    Clin Chem Lab Med; 2017 Mar; 55(3):441-446. PubMed ID: 27754959
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
    Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
    Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening.
    Morris LF; Waguespack SG; Edeiken-Monroe BS; Lee JE; Rich TA; Ying AK; Warneke CL; Evans DB; Perrier ND; Grubbs EG
    Ann Surg Oncol; 2013 Jan; 20(1):53-9. PubMed ID: 22890595
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
    Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
    Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature.
    Appetecchia M; Barnabei A; Pompeo V; Sentinelli S; Baldelli R; Corsello SM; Torino F
    BMC Endocr Disord; 2014 Oct; 14():84. PubMed ID: 25306429
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prediction of lateral neck lymph node metastasis according to preoperative calcitonin level and tumor size for medullary thyroid carcinoma.
    Bae SY; Jung SP; Choe JH; Kim JS; Kim JH
    Kaohsiung J Med Sci; 2019 Dec; 35(12):772-777. PubMed ID: 31483088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers.
    Giovanella L; Crippa S; Cariani L
    Int J Biol Markers; 2008; 23(2):129-31. PubMed ID: 18629788
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High Ratio of Early Postoperative Calcitonin to Preoperative Calcitonin Could be a Novel Indicator of Poor Prognosis in Patients with Biochemical Incomplete Responses in Sporadic Medullary Thyroid Cancer.
    Chen L; Sun W; Qian K; Guo K; Sun T; Wu YI; Wang Z
    Endocr Pract; 2020 Jul; 26(7):738-747. PubMed ID: 33471642
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread?
    Hotz HG; Runkel NS; Frank-Raue K; Raue F; Buhr HJ
    Langenbecks Arch Surg; 1998 Apr; 383(2):170-3. PubMed ID: 9641893
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.
    Alzumaili B; Xu B; Spanheimer PM; Tuttle RM; Sherman E; Katabi N; Dogan S; Ganly I; Untch BR; Ghossein RA
    Mod Pathol; 2020 Sep; 33(9):1690-1701. PubMed ID: 32313184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Recommendation for Calcitonin Screening in Nodular Goiter].
    Frank-Raue K; Schott M; Raue F;
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1065-1069. PubMed ID: 30060274
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.
    Peixoto Callejo I; Américo Brito J; Zagalo CM; Rosa Santos J
    Clin Transl Oncol; 2006 Jun; 8(6):435-43. PubMed ID: 16790397
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
    He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.